Trial Profile
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2018
Price :
$35
*
At a glance
- Drugs Nafithromycin (Primary) ; Nafithromycin (Primary)
- Indications Community-acquired pneumonia; Haemophilus infections
- Focus Pharmacokinetics
- Sponsors Wockhardt
- 31 Jul 2018 Status changed from recruiting to completed.
- 10 Aug 2016 New trial record